Gene · 2925
Papers2,036
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,036
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Estimation of Human Absorbed Dose of 188Re-Hynic-Bombesin Based on Biodistribution Data in Rats. | Curr Radiopharm | 2023 | 36121093 | PubTator, text mining | PubMed |
| Value of 68Ga-labeled bombesin antagonist (RM2) in the detection of primary prostate cancer comparing with [18F]fluoromethylcholine PET-CT and multiparametric MRI-a phase I/II study. | Eur Radiol | 2023 | 35864350 | PubTator, text mining | PubMed |
| Grpr expression defines a population of superficial dorsal horn vertical cells that have a role in both itch and pain. | Pain | 2023 | 35543635 | PubTator, text mining | PubMed |
| Clinical Pharmacology of Radiotheranostics in Oncology. | Clin Pharmacol Ther | 2023 | 35373336 | PubTator, text mining | PubMed |
| Dual targeting with 224Ra/212Pb-conjugates for targeted alpha therapy of disseminated cancers: A conceptual approach. | Front Med (Lausanne) | 2022 | 36733936 | PubTator, text mining | PubMed |
| Quality of life and informational needs for allogeneic hematopoietic stem cell transplant among patients and their caregivers visiting long-term follow-up clinic. | Blood Cell Ther | 2022 | 36710950 | PubTator, text mining | PubMed |
| Human Dose Assessment of 68Ga-NODAGA-RGD-BBN Heterodimer Peptide based on Animal Data. | J Med Phys | 2022 | 36684706 | PubTator, text mining | PubMed |
| Development of radiopharmaceuticals for targeted alpha therapy: Where do we stand? | Front Med (Lausanne) | 2022 | 36619636 | PubTator, text mining | PubMed |
| Modern Developments in Bifunctional Chelator Design for Gallium Radiopharmaceuticals. | Molecules | 2022 | 36615397 | PubTator, text mining | PubMed |
| Targeting mTORC1 Activity to Improve Efficacy of Radioligand Therapy in Cancer. | Cancers (Basel) | 2022 | 36612012 | PubTator, text mining | PubMed |
| Unraveling the Chemistry of meso-Cl Tricarbocyanine Dyes in Conjugation Reactions for the Creation of Peptide Bonds. | ACS Bio Med Chem Au | 2022 | 36573095 | PubTator, text mining | PubMed |
| Bioorthogonal Chemistry Approach for the Theranostics of GRPR-Expressing Cancers. | Pharmaceutics | 2022 | 36559063 | PubTator, text mining | PubMed |
| Horizontal Transfer and Evolutionary Profiles of Two Tc1/DD34E Transposons (ZB and SB) in Vertebrates. | Genes (Basel) | 2022 | 36553507 | PubTator, text mining | PubMed |
| The top 100 most cited articles in the last two decades of atopic dermatitis: A bibliometric analysis. | Front Immunol | 2022 | 36532008 | PubTator, text mining | PubMed |
| Anti-GRP-R monoclonal antibody antitumor therapy against neuroblastoma. | PLoS One | 2022 | 36525420 | PubTator, text mining | PubMed |
| Editorial: Crosslinking ROS signaling and stem cells. | Front Cell Dev Biol | 2022 | 36518536 | PubTator, text mining | PubMed |
| Identification and validation of a prognostic risk-scoring model based on sphingolipid metabolism-associated cluster in colon adenocarcinoma. | Front Endocrinol (Lausanne) | 2022 | 36518255 | PubTator, text mining | PubMed |
| Short Linear Motifs in Colorectal Cancer Interactome and Tumorigenesis. | Cells | 2022 | 36496998 | PubTator, text mining | PubMed |
| Endocrine and paracrine characteristics of neuroendocrine prostate cancer. | Front Endocrinol (Lausanne) | 2022 | 36440195 | PubTator, text mining | PubMed |
| Delivery of Theranostic Nanoparticles to Various Cancers by Means of Integrin-Binding Peptides. | Int J Mol Sci | 2022 | 36430214 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2925/papers?page=16